---
figid: PMC4681826__LRT2015-757694.001
figlink: /pmc/articles/PMC4681826/figure/fig1/
number: Figure 1
caption: Signaling pathways activated by BCR-ABL. (a) BCR-ABL activates GRB-2/SOS
  which in turn activates RAS. Active RAS activates RAF. Active RAF stimulates MEK1,
  which in turn activates ERK1/2. Activation of Ras pathway by BCR-ABL aids CML cells
  proliferation. On the other hand, activated GRB-2/SOS stimulates GAB2 which activates
  PI3-K pathway. (b) BCR-ABL phosphorylates adaptor proteins like CRK and CRKL leading
  to the activation of PI3-K. PI3-K phosphorylates PIP2 to PIP3 which in turn activates
  AKT. AKT inhibits p27 leading to CML cells proliferation. AKT phosphorylates MDM2,
  which in turn inhibit p53. AKT activates NFκB via phosphorylation of IKK and IkBα.
  AKT inhibits p-BAD. Activation of NFκB and inhibition of p53 and BAD by AKT evade
  apoptosis and promote CML cells survival. (c) BCR-ABL phosphorylates STAT5 which
  also aid in evading apoptosis of CML cells. (d) BCR-ABL phosphorylate cytoskeleton
  proteins resulting in increased cellular motility and reduced adhesion to extracellular
  matrix of bone marrow.
pmcid: PMC4681826
papertitle: Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia.
reftext: Kalubai Vari Khajapeer, et al. Leuk Res Treatment. 2015;2015:757694.
pmc_ranked_result_index: '111966'
pathway_score: 0.9631593
filename: LRT2015-757694.001.jpg
figtitle: Signaling pathways activated by BCR-ABL
year: '2015'
organisms: Homo sapiens
ndex: a34a6249-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4681826__LRT2015-757694.001.html
  '@type': Dataset
  description: Signaling pathways activated by BCR-ABL. (a) BCR-ABL activates GRB-2/SOS
    which in turn activates RAS. Active RAS activates RAF. Active RAF stimulates MEK1,
    which in turn activates ERK1/2. Activation of Ras pathway by BCR-ABL aids CML
    cells proliferation. On the other hand, activated GRB-2/SOS stimulates GAB2 which
    activates PI3-K pathway. (b) BCR-ABL phosphorylates adaptor proteins like CRK
    and CRKL leading to the activation of PI3-K. PI3-K phosphorylates PIP2 to PIP3
    which in turn activates AKT. AKT inhibits p27 leading to CML cells proliferation.
    AKT phosphorylates MDM2, which in turn inhibit p53. AKT activates NFκB via phosphorylation
    of IKK and IkBα. AKT inhibits p-BAD. Activation of NFκB and inhibition of p53
    and BAD by AKT evade apoptosis and promote CML cells survival. (c) BCR-ABL phosphorylates
    STAT5 which also aid in evading apoptosis of CML cells. (d) BCR-ABL phosphorylate
    cytoskeleton proteins resulting in increased cellular motility and reduced adhesion
    to extracellular matrix of bone marrow.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - BAD
  - MAP2K2
  - MDM2
  - MAP2K1
  - PIK3CG
  - AKT1
  - CBL
  - PIK3CD
  - HRAS
  - BCL2L1
  - RAF1
  - BRAF
  - AKT3
  - PIK3R3
  - KRAS
  - NRAS
  - NFKB1
  - NFKB2
  - CHUK
  - IKBKB
  - SOS1
  - PIK3CB
  - MAPK1
  - CRK
  - IKBKG
  - ARAF
  - PIK3CA
  - STAT5A
  - CRKL
  - MAPK3
  - RELA
  - RELB
  - GRB2
  - NFKBIA
  - STAT5B
  - PIK3R4
  - GAB2
  - REL
  - TP53
  - PIK3R6
  - PIK3R5
  - SOS2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CBL
  symbol: CBL
  source: hgnc_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Bcl-xL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CRK
  symbol: CRK
  source: hgnc_symbol
  hgnc_symbol: CRK
  entrez: '1398'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: CRKL
  symbol: CRKL
  source: hgnc_symbol
  hgnc_symbol: CRKL
  entrez: '1399'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: GRB-2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: GAB2
  symbol: GAB2
  source: hgnc_symbol
  hgnc_symbol: GAB2
  entrez: '9846'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
